Showing 1631-1640 of 2150 results for "".
- Academy 2019 Orlando and 3rd World Congress of Optometry Education Program Announcedhttps://modernod.com/news/academy-2019-orlando-and-3rd-world-congress-of-optometry-education-program-announced/2476458/The World Council of Optometry and the American Academy of Optometry have partnered to present an impressive education program taking place at Academy 2019 Orlando and the 3rd World Congress of Optometry, October 23 to 27, 2019. This joint meeting will bring global optometry together t
- National Cancer Institute Director Ned Sharpless to Become Acting FDA Headhttps://modernod.com/news/national-cancer-institute-director-ned-sharpless-to-cecome-acting-fda-head/2476373/Ned Sharpless, MD, the current director of the US National Cancer Institute (NCI), will assume the position of acting chief of the FDA when Scott Gottlieb, MD, steps down next month. Dr. Gottlieb, who recently tendered his resignation from the role, is said to have recommended Dr. Sharpless for t
- Gottlieb’s Quick Goodbye Triggers Investor Panic, Biopharma Bewildermenthttps://modernod.com/news/gottliebs-quick-goodbye-triggers-investor-panic-biopharma-bewilderment/2476360/When FDA Commissioner Scott Gottlieb got his job, critics called him a shill and industry types figured they’d gained a friend in the most important drug regulatory agency in the world. It didn’t turn out quite that way. Gottlieb was biopharma-friendly—to the point where the Na
- University of Alberta Scientists Pinpoint a Cause of Pigmentary Glaucomahttps://modernod.com/news/university-of-alberta-scientists-pinpoint-a-cause-of-pigmentary-glaucoma/2476337/An international team of researchers has identified a gene responsible for the onset of pigmentary glaucoma, which may lead to new therapies for the condition. “People who traditionally we wouldn’t think of having glaucoma—young males in their 20s and 30s—are at particular risk
- Eyegate Pharma Announces Positive Results in Punctate Epitheliopathy Studyhttps://modernod.com/news/eyegate-pharma-announces-positive-results-in-punctate-epitheliopathy-study/2479668/EyeGate Pharmaceuticals announced topline data from its study evaluating the potential of EyeGate’s Ocular Bandage Gel (OBG) to help clinicians better manage patients with punctate epitheliopathies (PE) due to pathologies such as dry eye. “A product t
- Eyegate Pharma Announces Positive Results in Second PRK Studyhttps://modernod.com/news/eyegate-pharma-announces-positive-results-in-second-prk-study/2479671/EyeGate Pharmaceuticals announced topline data from its study evaluating the potential of EyeGate’s Ocular Bandage Gel (OBG) to help clinicians better manage corneal epithelial defects in patients following photorefractive keratectomy (PRK) surgery, compared to current standard of care. “T
- Reay H. Brown, MD, Joins Sight Sciences as Chief Medical Officerhttps://modernod.com/news/reay-h-brown-md-joins-sight-sciences-as-chief-medical-officer/2479741/Sight Sciences announced that Reay H. Brown, MD, has joined the company as Chief Medical Officer (CMO). Dr. Brown is one of the most prolific inventors and innovators in the history of surgical glaucoma. He was the original inventor of trabecular microbypass stenting, which has served as t
- CooperVision Introduces Online Training to Help ECPs Upgrade Contact Lens Patients to Silicone Hydrogel 1-Day Lenseshttps://modernod.com/news/coopervision-introduces-online-training-to-help-ecps-upgrade-contact-lens-patients-to-silicone-hydrogel-1-day-lenses/2479834/To help eye care professionals grow their silicone hydrogel 1-day contact lens business, CooperVision is unveiling a new, comprehensive online training program that can be completed at any place and time. The web-based training and on-demand webinar focus on teaching practitioners and staff how t
- Artificial Intelligence in Ophthalmology: A Brave New World Cominghttps://modernod.com/news/artificial-intelligence-in-ophthalmology-a-brave-new-world-coming/2479934/Artificial intelligence (AI) has been heralded as part of “the fourth industrial revolution,” along with Internet of Things, blockchain, and edge computing. All are methods of collecting, analyzing, and storing information and viewed as possessing the same life-changing potential as t
- Ocular Therapeutix Announces FDA Acceptance of NDA Resubmission for Dextenzahttps://modernod.com/news/ocular-therapeutix-announces-fda-acceptance-of-nda-resubmission-for-dextenza/2480009/Ocular Therapeutix announced that it has received acknowledgement from the FDA that the new drug application (NDA) for Dextenza has been received. Dextenza (dexamethasone insert) 0.4 mg is Ocular Therapeutix’s lead product candidate for the treatment of ocular pain following ophthalmic surgery. T